New York trial tests heartburn medication against COVID-19

Published: April 27, 2020 at 2:35 a.m. ET

A trial in a New York hospital is testing the heartburn medication Pepcid as a treatment for COVID-19, according to a report in Science. Pepcid, a generic drug marketed by Merck
MRK,
+0.68%
and Johnson & Johnson
JNJ,
-0.41%,
is being tested on 187 COVID-19 patients in critical status at Northwell Health in the New York City area.